Quick answer
GHK-KPV is a six-residue synthetic research peptide (Gly-His-Lys-Lys-Pro-Val) that covalently joins the copper-binding tripeptide GHK to KPV, the C-terminal tripeptide of alpha-MSH, so that both motifs can be studied in a single molecule.
- Structure: head-to-tail fusion of GHK and KPV; molecular mass under 700 Da, strongly basic and highly water-soluble
- Central research question: whether covalent linkage produces readouts that GHK, KPV or an unfused mixture do not
- Essential controls: GHK alone, KPV alone and a noncovalent mixture, tested at matched concentrations
- Handling: use metal-free labware (GHK binds copper), protect from light, aliquot working stock; stock math is in the calculator
- Available as: GHK-KPV research vials, with identity and purity documented on a lot COA
GHK-KPV is a designed molecule, not a discovered one, and that fact shapes how its literature should be read. Two short sequences with separate research histories were joined into one chain, and almost everything written about the hybrid is inferred, in part, from what is known about the parents. This guide separates what belongs to GHK, what belongs to KPV and what can only be learned by studying the fused molecule itself, and it covers structure, mechanism, model design, handling and quality documentation. For laboratory research use only; not for human consumption. The material below concerns chemistry and controlled laboratory models only.
What GHK-KPV is
GHK-KPV is a hexapeptide with the sequence Gly-His-Lys-Lys-Pro-Val. The first three residues are the GHK motif (glycyl-L-histidyl-L-lysine), a tripeptide best known for high-affinity copper(II) binding. The last three are KPV (L-lysyl-L-prolyl-L-valine), the C-terminal fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). The combined chain has a molecular mass under 700 Da, which places it among the smaller research peptides.
The construct is used as a laboratory tool to ask a narrow question: does physically linking a metal-binding motif to a regulatory tripeptide change the measurable behavior of either half? Because the answer cannot be assumed from the parents, the hybrid should be characterized as its own research material. A product name alone does not specify copper occupancy, terminal state, counterion or whether the motifs are covalently fused, so the sequence and analytical record for the material in hand are the authoritative description.
Related background is available for each parent: GHK-Cu research for the copper-peptide half, and what is KPV for the other. The hybrid itself is listed on the GHK-KPV product page.
Discovery and history
There is no single discovery event for GHK-KPV. Its story is the deliberate merging of two established ideas, which places it in the history of rational peptide construction rather than among naturally occurring peptide discoveries.
The GHK heritage
GHK was identified in human plasma in the early 1970s as a tripeptide that binds copper(II) with high affinity (reference 1), and it later became associated with matrix-related activity in connective-tissue models (reference 2). That record made it a natural anchor motif for hybrid design. Its own history is told in the GHK-Cu discovery and history article.
The KPV heritage
KPV followed a separate path. As the C-terminal tripeptide of alpha-MSH, it was studied by itself for a regulatory profile in inflammation-signaling models (reference 3 describes an intestinal-model example, and reference 4 reviews the parent hormone). Its background is covered in KPV discovery and history. For most of its research life KPV was examined independently of GHK.
Bringing the two together
Fusing the motifs into one chain is a comparatively modern move, made practical as solid-phase synthesis and analytical verification made short custom sequences easy to reproduce. It reflects a modular view in which a short sequence is a functional building block that can be connected to another motif with a different history. The same design philosophy is discussed in peptide blends and research stacks, although a fused chain differs from a blend in that stoichiometry is fixed at one to one.
Why historical precision matters
Neither the reputation of GHK nor that of KPV establishes the behavior of the fused molecule. Historical summaries have to distinguish evidence obtained with the parent peptides from observations made with the hybrid itself. Keeping those records separate prevents inherited assumptions from being mistaken for direct evidence and gives later model studies a cleaner baseline. The site's discovery and history page gives a shorter version of this account.
Chemical structure and synthesis
The chain is easiest to understand as two motifs sharing one backbone:
| Segment | Residues | Chemical character | Origin of interest |
|---|---|---|---|
| GHK motif | Gly-His-Lys | Free N-terminal amine and histidine imidazole form a copper(II) chelation site | Copper-peptide research since the early 1970s |
| KPV motif | Lys-Pro-Val | Compact; proline introduces a conformational constraint in the backbone | C-terminal fragment of alpha-MSH |
| Hybrid | Gly-His-Lys-Lys-Pro-Val | Six residues, strongly basic and hydrophilic; mass under 700 Da | Designed head-to-tail fusion |
Why orientation matters
The order of the residues fixes side-chain spacing, backbone direction and the accessibility of the amino and carboxyl termini. Reversing either motif would create a different molecule. Analytical records should therefore identify the full sequence instead of naming only the two components, and should state the terminal state, counterion and expected molecular mass because each affects how lots are compared. Background on reading sequences is in understanding amino acid sequences.
Solid-phase assembly
For research supply, the fused sequence is built by solid-phase peptide synthesis, adding one protected residue at a time on a resin support before cleavage and deprotection. The crude product is purified and lyophilized to a dry powder; the reasons freeze-drying suits peptides are explained in what is lyophilization.
Identity and purity verification
A hybrid sequence can be assembled incorrectly, with deletions or misordered residues giving closely related impurities. Identity and purity are therefore confirmed by HPLC and mass spectrometry together, which verify chain length and mass; the roles of the two techniques are compared in HPLC vs mass spectrometry. The construction is described further in the chemical structure and synthesis article.
An open chemistry question
One question that chemistry can address without assuming a biological outcome is whether copper coordination at the GHK end changes the conformation or analytical behavior of the adjoining KPV end. Binding assays and structural methods can compare the intact hybrid, free GHK, free KPV and an equimolar mixture to see whether covalent linkage alone changes any measurable property.
Mechanism of action
Because GHK-KPV is a covalent pairing of two distinct motifs, its proposed mechanism is best understood as two parallel hypotheses joined in one molecule, not as a single unified pathway. The site's mechanism of action article sets out the framework summarized here.
The GHK component
GHK is a high-affinity copper(II)-binding tripeptide, and much of its studied behavior is attributed to copper coordination and downstream effects on matrix-remodeling genes in cell models (references 2 and 5). The receptor and matrix framing for this half is covered in GHK-Cu mechanism of action.
The KPV component
KPV is studied for regulatory signaling in inflammation-model systems, with proposed intracellular actions that are chemically separate from copper coordination. Intestinal-cell work, for example, has examined uptake of the tripeptide through the peptide transporter PepT1 (reference 3). The background for this half is in KPV mechanism of action, and its relationship to the parent hormone is compared in KPV vs alpha-MSH.
Additive versus synergistic readouts
When two motifs are carried in one chain, a central question is whether observed effects are merely additive or genuinely synergistic. Answering it requires comparison with each motif alone, and it also requires attention to the covalent link, which fixes stoichiometry at one to one and may alter diffusion, conformation, protease accessibility or cellular association. For that reason the intact molecule cannot be treated as equivalent to a simple mixture.
Useful mechanistic readouts
| Readout | What it addresses | Limitation |
|---|---|---|
| Copper-binding measurements | Whether the GHK end still chelates Cu(II) in the fused chain | Says nothing about cellular activity |
| Transcriptional responses | Which gene programs shift under defined conditions | Cannot assign effect to one motif without comparators |
| Signaling markers | Receptor-independent signaling changes in cell models | Marker may be reached through either half |
| Stability over the assay interval | Whether intact hybrid persists or is cleaved to fragments | Needs analytical method able to resolve fragments |
Interpreting data from the combined molecule
Interpretation means attributing readouts to the correct motif and not to the hybrid as a black box. A single downstream marker cannot show which half generated it, which is why orthogonal measurements and time-course data with matched vehicle controls are used to separate an immediate chemical interaction from a later cellular response. In-vitro concentrations are set by assay design and carry no implication for any other setting.
Preclinical research findings
Published work on the hybrid itself is much thinner than the literature on its parents, and this guide does not claim specific outcomes for GHK-KPV that the site's source material does not support. What can be described reliably is the way model-system work is designed and how it should be read. The narrative version is in the preclinical research article.
| Study design element | Purpose | Typical implementation |
|---|---|---|
| Hybrid in cell culture | Characterize behavior of the fused sequence under defined, repeatable conditions | Vary concentration, exposure time and copper availability while holding other factors constant |
| GHK-alone comparator | Attribute copper-peptide-type readouts to the correct half | Matched molar concentration of free GHK |
| KPV-alone comparator | Attribute regulatory-signaling readouts to the correct half | Matched molar concentration of free KPV |
| Unfused mixture | Distinguish covalent linkage from simple co-presence | Equimolar GHK plus KPV as separate molecules |
| Stability tracking | Rule out readouts arising from released fragments | Measure intact material across the assay interval |
| Independent lots and models | Test robustness of any pattern | More than one batch, assay platform or cell type |
Two heritages under one study
The GHK half draws on a long record of copper-peptide matrix and connective-tissue work, summarized in GHK-Cu preclinical research. The KPV half carries a separate profile described in KPV preclinical research. Combination studies ask how those profiles coexist in a single chain.
Cell-based model preparations
Cell culture is the usual substrate for characterizing combination peptides because it allows controlled observation under repeatable conditions. Researchers can change concentration, exposure and copper availability while keeping everything else fixed, which is the practical route to separating the contribution of each motif.
Stability as an experimental variable
The fused chain may not share the degradation pattern of either isolated tripeptide. Protocols can track intact material across the assay interval and distinguish loss of the parent compound from formation of shorter fragments. This matters because a readout attributed to GHK-KPV could in fact arise after cleavage releases one component, especially in systems containing extracellular or intracellular proteases.
Reporting mixed and negative results
Combination constructs can give strong, weak or discordant outcomes across assays, and all three patterns are informative. A lack of enhancement over the parent motifs argues against synergy under the tested conditions, while differences between cell types may point to context dependence. Defining endpoints before analysis, retaining raw analytical records and replicating across independently prepared material are the practices that keep such findings useful without extending them beyond the model studied.
Handling, reconstitution and storage
GHK-KPV is small, strongly basic and highly water-soluble, so it dissolves readily and rarely needs more than gentle swirling. Two compound-specific points deserve attention. First, the GHK end binds copper, so trace metal in glassware or diluent can change the chemistry of the solution; clean, metal-free labware avoids that variable. Second, the histidine side chain can be sensitive to oxidation over long periods in solution. The compound-specific page is GHK-KPV reconstitution and storage; the technique shown in the lyophilized-peptide reconstitution guide applies directly.
Preparing the solution
Let the vial reach room temperature before opening, use sterile technique, and add bacteriostatic water slowly down the inside wall of the vial rather than onto the cake (see bacteriostatic water explained). Dissolve by swirling; do not vortex or shake.
Concentration math
Stock concentration equals the mass in the vial divided by the diluent volume. The values below are illustrative for common vial masses; the calculator handles any combination and the calculator guide explains the inputs.
| Vial contents | Diluent added | Stock concentration |
|---|---|---|
| 5 mg | 1 mL | 5 mg/mL |
| 5 mg | 2 mL | 2.5 mg/mL |
| 10 mg | 2 mL | 5 mg/mL |
| 10 mg | 4 mL | 2.5 mg/mL |
Storage
The lyophilized powder is the most stable form and should be kept cold, dry and away from light. In solution, keep working stock cold, protected from light and divided into small aliquots, which limits oxidative drift. General cold-chain principles are in storing research peptides. Labs that run GHK-KPV beside its parent fragments usually apply identical handling to GHK-Cu and KPV so that comparisons are not confounded by storage differences.
Purity, COA and quality
Identity matters more than usual for a hybrid, since a misassembled chain can resemble the intended product in a simple purity percentage. A useful lot record includes:
- HPLC purity supported by a chromatogram, with the integration method stated
- Mass spectrometry confirming the expected molecular mass of the full six-residue chain
- Terminal state and counterion information, which affect measured mass and concentration calculations
- A lot number that matches the vial
Results appear on the COA page; interpretation is covered in how to read a COA and understanding HPLC purity. The compound-specific analytical breakdown is in GHK-KPV purity testing, and sourcing criteria are discussed in what a legitimate listing looks like. Current vials are on the product page.
Related compounds and comparisons
- KPV is the other parent; the KPV product page and KPV vs other research peptides place it among related materials.
- KPV vs alpha-MSH explains how the fragment relates to the full melanocortin hormone.
- Peptide blends and research stacks contrasts physical blends with fused constructs.
The practical distinction is that a blend contains separate molecules whose behavior can diverge, while the fused hybrid keeps both motifs at fixed one-to-one stoichiometry.
Frequently asked questions
What is GHK-KPV, structurally?
A single covalent chain, Gly-His-Lys-Lys-Pro-Val, joining the copper-binding tripeptide GHK to the C-terminal tripeptide KPV. Details are in the chemistry article.
Does the fused molecule behave like a mixture of the two peptides?
Not necessarily. Covalent linkage fixes stoichiometry and may alter conformation, diffusion or protease access, so comparison against GHK alone, KPV alone and an unfused mixture is standard design.
How does the GHK half relate to GHK-Cu research?
The copper-coordination chemistry of the GHK motif draws on the same foundational work described in the GHK-Cu overview. Whether the fused chain is copper-occupied depends on the material, so check the record for the lot.
What does the KPV half contribute?
A regulatory-signaling profile studied independently, proposed to act through intracellular pathways distinct from copper binding. See the KPV mechanism article.
Why study a combined peptide rather than two separate ones?
A fused tool lets researchers observe potential interactions between two motifs at fixed stoichiometry within one model. The interpretive caveats of combination designs are covered in peptide blends and research stacks.
Can findings for GHK or KPV be applied to GHK-KPV?
Not automatically. Fusion changes mass, terminal groups, local charge and susceptibility to cleavage, so conclusions should be restricted to the system in which the hybrid itself was tested.
How is a GHK-KPV lot verified?
By a certificate of analysis confirming the identity and purity of the full sequence through HPLC and mass spectrometry. See how to read a COA.
Why does labware matter for this peptide?
The GHK end binds copper, so trace metal contamination in glassware or diluents can change the solution chemistry. Metal-free labware removes that variable.
How is the powder stored?
Cold, dry and protected from light in lyophilized form. After reconstitution, keep it cold, shielded from light and aliquoted; see reconstitution and storage.
What would count as evidence of synergy?
A readout from the intact hybrid that exceeds what the two separate motifs, and their unfused mixture, produce at matched concentrations, reproduced across independent lots and more than one model.
Research use and scope
For laboratory research use only; not for human consumption. GHK-KPV is supplied for in-vitro and preclinical research by qualified investigators. Findings described here belong to controlled laboratory systems and should not be extended beyond the model studied. Concentration figures are laboratory stock calculations only. Research vials are available from the GHK-KPV product page.
References
- Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver cells. Nature New Biology. 1973;243:85-87.
- Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. 1988;238(2):343-346.
- Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178.
- Brzoska T, Luger TA, Maaser C, Abels C, Bohm M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Reviews. 2008;29(5):581-602.
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2018;19(7):1987.